InstructorRoyed Training
TypeOnline Course
Student Enrolled5
Price$490 / 27500 INR
Buy NowBook Now
inlicensing outlicensing training


Who should attend

Course Features

Related Courses

About in and out licensing

Course Upgrade

inlicensing and outlicensing in pharmaceutical and biopharmaceutical industry

This licensing online training course provides advanced practical real life training on inlicensing and outlicensing deal. In fact the course covers entire strategic aspects of the in and out licensing deal. Hence, pharmaceutical inlicensing and outlicensing course guides each participant through licensing deal. Hence, it ensures in-depth understanding on profiling to due diligence process. Moreover, the course will focus on portfolio analysis and strategies for successful product pipeline management. Above all, the course provides hands on training on biopharmaceutical brand valuation tools and techniques.

  • Course Code: RYD-022
  • Title of the training: Certificate course in Inlicensing and Outlicensing in Pharmaceutical and Biopharmaceutical Industry
  • Duration of the course: 1 Month
  • Eligibility: Any body who wants to acquire inlicensing and outlicensing related job competency should attend the course.
  • Certification: Certificate will be provided at the end of the successful completion of the course.

Self Paced Learning

Being self paced learning, it is convenient for working executives. In fact, it allows the user to stop and start at their leisure. More importantly, the course is designed to challenge students to apply what they have learned through the use of interactive exercises, reflection questions and a final assessment at the end of the course.

Who should attend this biopharma inlicensing and outlicensing training?

  • First of all, this inlicensing and licensing course is ideal for Pharmaceutical and Biopharmaceutical professionals working in business development, strategic management and licensing department.
  • Secondly, this course will be ideal for Biopharmaceutical R&D professional to understand biopharma inlicensing and outlicensing deal.
  • In fact, it is ideal resource for those wishing to update their knowledge on portfolio management strategies.
  • Also, this will provides cutting-edged training for Pharmaceutical project management and Biopharmaceutical Project Management.

Features of the Course:

  • Orientation to practical understanding licensing deals – specifically in inlicensing and outlicensing in pharma and biopharma industry
  • Simulation to real life Regulatory Strategic planning for licensing in pharma business.
  • Course provides comprehensive understanding on market forecasting, valuation techniques and deal financial analytics.
  • Practical training in drafting of licensing deals.
  • Focus on due diligence in pharmaceutical and biopharmaceutical licensing deals.

Here are some related courses:

What is in licensing and out licensing?

If I license a product from Company A and there is a Company B who will get the license for that product from Company A. Then, Company B is in-licensing it and Company A is outlicensing it.

What is out licensing in pharma?

Outlicensing is more focused on opening up the delivery pipeline to assist you with getting your drug “out the door.” Outlicensing encompasses finding a partnership, or partnerships, that will help identify your target market and assist you in getting your product into the right hands.

What does Licensing mean in business?

Definition: A business arrangement in which one company gives another company permission to manufacture its product for a specified payment. There are few faster or more profitable ways to grow your business than by licensing patents, trademarks, copyrights, designs, and other intellectual property to others.

Can I extend this course for more than 1 month?

In general, this course is having duration of 1 month. But you can increase your course subscription period of your need. What we mean, if you require to increase the course duration for 2 month or 3 month, you can do so. Kindly keep in touch our support team at, they will assist you further.

Course Upgrade

From PG Certification in Pharma Marketing, one can upgrade to one of the following courses.

Course upgrade is possible by paying a difference in course fees. Hence, one will not be paying the full course fees of pharma global management. Course participants need to pay only the difference in course fees.

Section 1Core Fundamental Sessions
Lecture 1Introduction | Download modules
Lecture 2Regulatory Strategies in different phases of Clinical Trial
Lecture 3Patents Vs. exclusivity 
Lecture 4R&D Process & Introduction to drug discovery
Lecture 5Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 6Portfolio Management in R&D Lifecycle 
Lecture 7Evergreening - Patent Life Extension Strategies
Lecture 8Compulsory Licensing
Lecture 9Licensing & Technology Transfer
Lecture 10In-Licensing Vs. Outlicensing
Lecture 11LOE Strategies for Innovator Brands with case study
Lecture 12Types of Deals from Discovery to Commercialization
Lecture 13Sales Forecasting in Life Science Industry
Lecture 14New Product Forecast Algorithm
Lecture 15Patient Based Forecasting Model | Applying more filters and variable
Lecture 16Prescription Based Forecasting Model | Differences between Patient Based and Prescription Based Forecasting Model | Which model to use and when?
Lecture 17Prevalence Vs. Incidence Model
Lecture 18EPI Based Forecasting | Sales Based Forecasting | When and where to apply which forecasting model
Lecture 19Sales Forecasting Tools | New Product Forecasting | In Market Forecasting
Lecture 20Market Size Assignment 1 [Oncology Brand] - Applying sales forecasting tools to carry out next 6 years sales forecast | Excel Based Model
Lecture 21Market Size Assignment 2 [Asthma Brand] - Applying sales forecasting tools to carry out multiple years sales forecast | Excel Based Model
Lecture 22Patient Based Model Vs. Patient Flow Model | Critical Differences in Model | Concept of Black Box in Patient Flow Model | Application of both model
Lecture 23Concomitancy and polypharmacy | How it alter the basic forecasting algorithm | Practical Working | Comorbidity
Lecture 24Forecasting Techniques | Simple Conjoint-type Models | Zipf's Law | Simple Elasticity Model | The Bass Model |Simple Extrapolation
Lecture 25Bottom-up or Top-down Forecasting | LRx | Significance of LRx data analysis
Lecture 26Simulation on Bottom-up forecasting
Lecture 27Assessment on Bottom-up forecasting
Lecture 28Oncology Brand Forecasting
Lecture 29QALY | How to calculate QALY | Importance and Significance 
Lecture 30ICER | How to calculate ICER | Importance and Significance | Incremental Therapy Value Proposition 
Lecture 31Patent Cliff | How to calculate the patent cliff
Lecture 32Portfolio Based Forecasting | Forecasting Model Development in Excel 
Lecture 33Data Exclusivity and Market Protection - Supplementary Patent Protection, Exclusivity, 6/10 Rule, 8+2+1 Formulae
Section 2Advanced Learning Sessions
Lecture 34Types of Strategic Alliances: Unilateral technology licensing | Cross technology licensing | R&D contracts | R&D collaborations | Minority-equity-based R&D alliances | JV | Manufacturing and marketing agreements of big pharma firms with dedicated biotechnology firms 
Lecture 35Market Size Determination - Market Share | Relative Market Share | Total Vs. Actual Vs. Penetrated Market
Lecture 36Licensing - Advance Learning 
Lecture 37Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets
Lecture 38Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department 
Lecture 39Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT
Lecture 40Profiling and Searching | Objectives | Search Database | Creating Opportunity Anatomy for deal analysis | Mind Mapping | Searching Tools and Techniques - Web Search | Conference | Confidentaility - CDA | MTA
Lecture 41Numerical SWOT Practical training
Lecture 42Modelling and Deal Valuation - Top Down Model | Epidemiology data method | Complex Model | Forecasting | Heuristic or ‘prophesy’ method | Different value perspectives | Deal Structuring Structuring the deal
Lecture 43Royalty Management - Royalty structuring | Royalty Calculation Method| Tiered Royalties | Terms | Royalty Reductions | Royalty Stacking - Concept and Calculation | Minimum Annual Royalties | Reach through royalties
Lecture 44Average Royalty Rate
Lecture 45Factors affecting royalty rate
Lecture 46Distribution Licensing | Geography | Indication Splitting | Execlusive and Non-Exclusive Licensing | Sub Licenses
Lecture 47Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 48Licensing Term Sheet | Content Structuring | Sample Term Sheet
Lecture 49Licensing Payment Scheduling: Different Types
Lecture 50Valuation Methods: DCF | rNPV | Sunk Cost Method | Comparables | Sum of Parts | Deterministic Vs. Probabilistic rNPV |  Peak Sales - Max-Min Approach
Lecture 51Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation
Lecture 52Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model
Lecture 53Licensing Agreement : Confidentiality Agreement | MTA | A deed of Assignment | Exclusive | Non-Exclusive License | Sole License | Components - Terms - Duration - Key Considerations
Lecture 54Step By Step Implementation of Licensing Deal by Business Development Team 
Lecture 55Value Share Principle | Discounting of licensing deal | Discount Rate